MedTrace Logo

Evaluation of Coagulation Factors and Point-of-care Devices During Veno-venous ECMO Therapy

NCT03754868 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2018-11-27

No results posted yet for this study

Summary

Hemorrhagic and thromboembolic complications are common in Veno-venous ECMO therapy. The aim of this study is to provide a detailed analysis of the activity of different coagulation factors and changes in functional coagulation measurements as in rotational thrombelastometry and multiple electrode aggregometry in the course of ECMO therapy.

Conditions

  • Extracorporeal Membrane Oxygenation Complication
  • Coagulation Factor Deficiency

Interventions

DIAGNOSTIC_TEST

Detailed coagulation monitoring

Monitoring of coagulation using activity of coagulation factors, rotational thrombelastometry and multiple electrode aggregometry

Sponsors & Collaborators

  • University Hospital Goettingen

    lead OTHER

Principal Investigators

  • Onnen Moerer, Prof. · Department of Anesthesiology, University Medical Center Goettingen

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03754868 on ClinicalTrials.gov